Question 1

What is the catalog number for CHO Monoclonal CD40/TNFRSF5 Antibody (dacetuzumab) - Humanized - (Dry Ice)?

Accepted Answer

The catalog number for CHO Monoclonal CD40/TNFRSF5 Antibody (dacetuzumab) - Humanized - (Dry Ice) is NBP3-28643-100ug.

Question 2

What sizes are available for CHO Monoclonal CD40/TNFRSF5 Antibody (dacetuzumab) - Humanized - (Dry Ice)?

Accepted Answer

CHO Monoclonal CD40/TNFRSF5 Antibody (dacetuzumab) - Humanized - (Dry Ice) is available in the following size(s): 100 µg.

Question 3

Is CHO Monoclonal CD40/TNFRSF5 Antibody (dacetuzumab) - Humanized - (Dry Ice) in stock?

Accepted Answer

CHO Monoclonal CD40/TNFRSF5 Antibody (dacetuzumab) - Humanized - (Dry Ice) is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

Is there an additional fee for hazardous or dry ice shipping of this product?

Accepted Answer

Yes, if this product requires dry ice or is classed as hazardous for transport, the additional fee will be explicitly shown in your quotation before you confirm the order, so there are no surprise charges later.

Question 5

How many freeze-thaw cycles can this product tolerate?

Accepted Answer

We recommend aliquoting the product upon receipt to avoid repeated freeze-thaw cycles, which can reduce activity and stability. This is your responsibility once the product has been delivered.

Question 6

Is antigen retrieval required for IHC with this antibody?

Accepted Answer

Recommended antigen retrieval methods, where applicable, are listed on the datasheet under the IHC protocol section.

CHO Monoclonal CD40/TNFRSF5 Antibody (dacetuzumab) - Humanized - (Dry Ice)

Product Specifications

Frequently Asked Questions

Explore Other Products

HIF1 alpha (Hypoxia-Inducible Factor 1-alpha) (ESEE122), CF568 conjugate, 0.1mg/mL

Anti-NSL1 Antibody Picoband®

YBX1 / Y-box Binding Protein 1 / YB-1 (Tumor Biomarker) (YBX1/2430), 1mg/mL

Anti-Glypican 3/GPC3 Antibody Picoband®

Cytokeratin 19 (KRT19/799), Biotin conjugate, 0.1mg/mL

Cytokeratin 8/18 (C-51), CF594 conjugate, 0.1mg/mL